Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
7.69
+0.02 (0.26%)
Apr 22, 2026, 1:35 PM CST
SHE:002566 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 63.55 | 71.48 | 487.73 | 343.26 | 219.7 |
Short-Term Investments | - | - | - | - | 30.08 |
Trading Asset Securities | 507.57 | 459.67 | 102.98 | 59.84 | 70.16 |
Cash & Short-Term Investments | 571.13 | 531.15 | 590.72 | 403.11 | 319.94 |
Cash Growth | 7.53% | -10.08% | 46.54% | 25.99% | 11.48% |
Accounts Receivable | 214.89 | 199.03 | 198.53 | 264 | 254.84 |
Other Receivables | 20.9 | 15.36 | 11.75 | 22.23 | 39.61 |
Receivables | 235.79 | 214.39 | 210.28 | 286.23 | 294.45 |
Inventory | 1,581 | 1,626 | 1,617 | 1,603 | 1,597 |
Other Current Assets | 9.87 | 3.75 | 13.32 | 10.17 | 10.53 |
Total Current Assets | 2,398 | 2,376 | 2,431 | 2,303 | 2,222 |
Property, Plant & Equipment | 417.13 | 450.34 | 483.66 | 526.11 | 501.49 |
Long-Term Investments | - | 15.23 | - | - | - |
Goodwill | 1.91 | 1.91 | 1.91 | 1.91 | 1.91 |
Other Intangible Assets | 108.66 | 111.35 | 114.18 | 117.03 | 119.96 |
Long-Term Deferred Tax Assets | 15.85 | 13.15 | 12.62 | 14.2 | 15.2 |
Long-Term Deferred Charges | 1.54 | 2.15 | 2.02 | 3.07 | 2.99 |
Other Long-Term Assets | 16.73 | 0.76 | 1.27 | 1.68 | 1.04 |
Total Assets | 2,960 | 2,971 | 3,047 | 2,967 | 2,864 |
Accounts Payable | 11.69 | 13 | 24.86 | 24.33 | 19.81 |
Accrued Expenses | 7.67 | 22.26 | 32.51 | 30.68 | 48.11 |
Short-Term Debt | 288.23 | 290.28 | 470.43 | 430.43 | 397.86 |
Current Portion of Long-Term Debt | 2.7 | 0.42 | - | - | 2.55 |
Current Portion of Leases | - | 2.98 | 2.34 | 3.29 | 3.31 |
Current Income Taxes Payable | 9.18 | 0.01 | 2.78 | 0.64 | 5.55 |
Current Unearned Revenue | 14.77 | 5.49 | 11.01 | 24.51 | 16.72 |
Other Current Liabilities | 49.86 | 31.55 | 45.91 | 74.29 | 39.84 |
Total Current Liabilities | 384.1 | 366 | 589.85 | 588.16 | 533.75 |
Long-Term Debt | 129.7 | 149.7 | - | - | - |
Long-Term Leases | 5.34 | 6.21 | 4.03 | 9.82 | 11.46 |
Long-Term Unearned Revenue | 108.87 | 112.54 | 118.69 | 118.02 | 120.85 |
Long-Term Deferred Tax Liabilities | 2.34 | 2.77 | 1.74 | 1.17 | 0.02 |
Total Liabilities | 630.35 | 637.22 | 714.3 | 717.18 | 666.08 |
Common Stock | 330.95 | 330.95 | 330.95 | 330.95 | 330.95 |
Additional Paid-In Capital | 834.69 | 834.69 | 834.69 | 834.69 | 834.69 |
Retained Earnings | 1,066 | 1,070 | 1,068 | 989.34 | 916.17 |
Total Common Equity | 2,232 | 2,236 | 2,233 | 2,155 | 2,082 |
Minority Interest | 97.76 | 97.83 | 99.26 | 94.45 | 116.47 |
Shareholders' Equity | 2,329 | 2,333 | 2,332 | 2,249 | 2,198 |
Total Liabilities & Equity | 2,960 | 2,971 | 3,047 | 2,967 | 2,864 |
Total Debt | 425.97 | 449.59 | 476.8 | 443.55 | 415.18 |
Net Cash (Debt) | 145.16 | 81.56 | 113.92 | -40.44 | -95.24 |
Net Cash Growth | 77.97% | -28.40% | - | - | - |
Net Cash Per Share | 0.44 | 0.25 | 0.34 | -0.12 | -0.29 |
Filing Date Shares Outstanding | 331.23 | 330.95 | 330.95 | 330.95 | 330.95 |
Total Common Shares Outstanding | 331.23 | 330.95 | 330.95 | 330.95 | 330.95 |
Working Capital | 2,014 | 2,010 | 1,841 | 1,714 | 1,688 |
Book Value Per Share | 6.74 | 6.76 | 6.75 | 6.51 | 6.29 |
Tangible Book Value | 2,121 | 2,122 | 2,117 | 2,036 | 1,960 |
Tangible Book Value Per Share | 6.40 | 6.41 | 6.40 | 6.15 | 5.92 |
Buildings | - | 548.14 | 548.14 | 545.7 | 400.71 |
Machinery | - | 353.49 | 359 | 357.13 | 321.57 |
Construction In Progress | - | - | - | 1.98 | 119.32 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.